A PEGylated fibrin-based wound dressing with antimicrobial and angiogenic activity.

Wounds sustained under battlefield conditions are considered to be contaminated and their initial treatment should focus on decreasing this contamination and thus reducing the possibility of infection. The early and aggressive administration of antimicrobial treatment starting with intervention on the battlefield has resulted in improved patient outcomes and is considered the standard of care. Chitosan microspheres (CSM) loaded with silver sulfadiazine (SSD) were developed via a novel water-in-oil emulsion technique to address this problem. The SSD-loaded spheres were porous with needle-like structures (attributed to SSD) that were evenly distributed over the spheres. The average particle size of the SSD-CSM was 125-180 μm with 76.50 ± 2.8% drug entrapment. As a potential new wound dressing with angiogenic activity SSD-CSM particles were impregnated in polyethylene glycol (PEGylated) fibrin gels. In vitro drug release studies showed that a burst release of 27.02% in 6h was achieved, with controlled release for 72 h, with an equilibrium concentration of 27.7% (70 μg). SSD-CSM-PEGylated fibrin gels were able to exhibit microbicidal activity at 125 and 100 μg ml(-1) against Staphylococcus aureus and Pseudomonas aeruginosa, respectively. The in vitro vasculogenic activity of this composite dressing was shown by seeding adipose-derived stem cells (ASC) in SSD-CSM-PEGylated fibrin gels. The ASC spontaneously formed microvascular tube-like structures without the addition of any exogenous factors. This provides a method for the extended release of an antimicrobial drug in a matrix that may provide an excellent cellular environment for revascularization of infected wounds.

[1]  R. Edlich,et al.  A new silver sulfadiazine water soluble gel. , 1997, Burns : journal of the International Society for Burn Injuries.

[2]  L. Perioli,et al.  Physicochemical characterization and release mechanism of a novel prednisone biodegradable microsphere formulation. , 2008, Journal of pharmaceutical sciences.

[3]  C. Rix,et al.  Solubility of silver sulfadiazine in physiological media and relevance to treatment of thermal burns with silver sulfadiazine cream. , 1995, Clinical chemistry.

[4]  T. S. Lakshmi,et al.  Controlled release of 2, 3 desulfated heparin exerts its anti-inflammatory activity by effectively inhibiting E-selectin. , 2010, Journal of biomedical materials research. Part A.

[5]  D. Herndon,et al.  Retardation of wound healing by silver sulfadiazine is reversed by Aloe vera and nystatin. , 2003, Burns : journal of the International Society for Burn Injuries.

[6]  T. E. Abraham,et al.  Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[7]  S. Uma,et al.  Design and delivery of silver sulfadiazine from alginate microspheres-impregnated collagen scaffold. , 2006, Journal of biomedical materials research. Part B, Applied biomaterials.

[8]  Ge Zhang,et al.  Vascular differentiation of bone marrow stem cells is directed by a tunable three-dimensional matrix. , 2010, Acta biomaterialia.

[9]  Laura J Suggs,et al.  Three-dimensional culture for expansion and differentiation of mouse embryonic stem cells. , 2006, Biomaterials.

[10]  T. S. Lakshmi,et al.  Efficacy of desulfated heparin mitigating inflammation in rat burn wound model. , 2011, Journal of biomedical materials research. Part B, Applied biomaterials.

[11]  Roland Bodmeier,et al.  Mechanical, water uptake and permeability properties of crosslinked chitosan glutamate and alginate films , 1997 .

[12]  Y. Ikada,et al.  Development of an artificial dermis preparation capable of silver sulfadiazine release. , 2001, Journal of biomedical materials research.

[13]  Laura Suggs,et al.  A PEGylated fibrin patch for mesenchymal stem cell delivery. , 2006, Tissue engineering.

[14]  P Rod Dunbar,et al.  Human adipose‐derived stem cells: isolation, characterization and applications in surgery , 2009, ANZ journal of surgery.

[15]  D. Hospenthal,et al.  Incidence and bacteriology of burn infections at a military burn center. , 2010, Burns : journal of the International Society for Burn Injuries.

[16]  M. Babu,et al.  Comparative Physico-chemical and in Vitro Properties of Fibrillated Collagen Scaffolds from Different Sources , 2004, Journal of biomaterials applications.

[17]  D. Church,et al.  Burn Wound Infections , 2006, Clinical Microbiology Reviews.

[18]  H. N. Harrison.  Pharmacology of sulfadiazine silver. Its attachment to burned human and rat skin and studies of gastrointestinal absorption and extension. , 1979, Archives of surgery.

[19]  C. Rix,et al.  Passage of silver ions through membrane-mimetic materials, and its relevance to treatment of burn wounds with silver sulfadiazine cream. , 1997, Clinical chemistry.

[20]  S. Modak,et al.  Binding of silver sulfadiazine to the cellular components of Pseudomonas aeruginosa. , 1973, Biochemical pharmacology.

[21]  M Szycher,et al.  Modern Wound Dressings: A Systematic Approach to Wound Healing , 1992, Journal of biomaterials applications.

[22]  P. Kennedy,et al.  Burns, biofilm and a new appraisal of burn wound sepsis. , 2010, Burns : journal of the International Society for Burn Injuries.

[23]  W. Stallcup,et al.  Early Contribution of Pericytes to Angiogenic Sprouting and Tube Formation , 2004, Angiogenesis.

[24]  R. Tuan,et al.  Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells , 2010, Expert opinion on biological therapy.

[25]  Clinical,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : Approved standard , 2006 .

[26]  A. Burd.  Evaluating the use of hydrogel sheet dressings in comprehensive burn wound care. , 2007, Ostomy/wound management.

[27]  T. S. Lakshmi,et al.  Preparation and characterization of chitosan microspheres for doxycycline delivery , 2008 .

[28]  T. Franz.  The finite dose technique as a valid in vitro model for the study of percutaneous absorption in man. , 1978, Current problems in dermatology.

[29]  T. Walters,et al.  Adipose-derived stem cell delivery into collagen gels using chitosan microspheres. , 2010, Tissue engineering. Part A.

[30]  L. DiPietro,et al.  Factors Affecting Wound Healing , 2010, Journal of dental research.

[31]  J. Perrot,et al.  [Increased serum and urinary levels of silver during treatment with topical silver sulfadiazine]. , 2002, Annales de dermatologie et de venereologie.

[32]  Antonios G Mikos,et al.  Repair of osteochondral defects with biodegradable hydrogel composites encapsulating marrow mesenchymal stem cells in a rabbit model. , 2010, Acta biomaterialia.

[33]  R. Masterton.  The new treatment paradigm and the role of carbapenems. , 2009, International journal of antimicrobial agents.

[34]  D. Katti,et al.  Electrospraying: a facile technique for synthesis of chitosan-based micro/nanospheres for drug delivery applications. , 2009, Journal of biomedical materials research. Part B, Applied biomaterials.

[35]  L. Cancio,et al.  Prevention and management of infections associated with burns in the combat casualty. , 2008, The Journal of trauma.

[36]  S. Sano,et al.  Absorption, excretion and tissue distribution of silver sulphadiazine. , 1982, Burns, including thermal injury.

[37]  S. Yuk,et al.  Dual growth factor-releasing nanoparticle/hydrogel system for cartilage tissue engineering , 2010, Journal of materials science. Materials in medicine.

[38]  P. Raymond,et al.  Improved method for obtaining 3-microns cryosections for immunocytochemistry. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[39]  R. Mathur,et al.  A comparative study to evaluate the effect of honey dressing and silver sulfadiazene dressing on wound healing in burn patients , 2009, Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India.